Transurban stock 'normally doesn't offer this level of value': expert

The recent market sell-off has seen the toll road operator lose 15.5% over the past 3 months.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here's what a share market in correction can do: It offers value buying on stocks that aren't usually cheap, with one current example being Transurban Group (ASX: TCL) shares.

That's according to Sarah Shaw, chief investment officer at 4D Infrastructure, who says she wouldn't normally recommend Transurban stock as a buying proposition for ordinary investors due to its valuation.

Transurban shares are $12.10 at the time of writing, up 1.3%.

empty toll road representing atlas arteria share price

Image source: Getty Images

Transurban stock suddenly a value buy: expert

The recent market sell-off has seen the S&P/ASX 200 Index (ASX: XJO) tumble 7% over three months.

It's taken Transurban shares with it, with the toll road operator losing 15.5% over the same period.

Hence Shaw's advocacy of the ASX industrial stock now.

In the Australian Financial Review (AFR) today, Shaw said:

I'd never normally say this – just because normally it doesn't offer this level of value – but Transurban has become a top 10 position for us, and it hasn't been a top 10 position for us in eight years.

I've never really been able to push it before, because it just hasn't offered the value that it is offering today.

Other experts agree with Shaw.

Atlas Funds Management points out that Transurban is trading at a 25% discount to its pre-COVID share price despite greater traffic volumes and higher toll prices due to inflation indexing.

Citi has a buy rating on Transurban stock with a 12-month share price target of $15.90, implying a potential 31% upside for investors who buy today.

Citi analysts "see upside given the strong EBITDA growth outlook (c.12% CAGR between FY24-FY26)."

Why is Transurban trading cheap?

Like many other ASX 200 shares, the Transurban share price has been brought down recently by the market sell-off.

A market enters official correction territory when it has fallen more than 10% from its most recent peak.

On 30 October, the ASX 200 breached that mark, trading 10.1% down from its February 52-week high.

Latest Transurban news

Transurban released its September quarter update on 19 October.

The company reported its highest-ever quarterly average daily traffic of 2.5 million trips per day.

Transurban also reaffirmed its FY24 distribution guidance of 62 cents per share, representing an approximate 7% lift on FY23.

The company advised the market of a $250 million notes issue and $220 million loan facility today.

New CEO takes the reins

Michelle Jablko recently ascended to the role of Transurban CEO and managing director after nearly three years as CFO.

She took the reins on 19 October at the conclusion of the annual general meeting.

The job change just netted her 204,309 extra performance awards on top of the 181,058 she already held, along with 47,250 extra STI deferred securities on top of the 31,750 she already held.

She also holds 67,169 Transurban shares directly.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »